Login / Signup

Survival impact of post-progression chemotherapy in advanced gastric cancer: systematic review and meta-analysis.

Sakura IizumiAtsuo TakashimaKentaro SakamakiSatoshi MoritaNarikazu Boku
Published in: Cancer chemotherapy and pharmacology (2018)
Post-Cx% both after 1st-Cx and 2nd-Cx were correlated with mOS/mPPS, suggesting a survival benefit of 3rd-Cx in addition to that of 2nd-Cx for AGC.
Keyphrases
  • free survival
  • neoadjuvant chemotherapy
  • squamous cell carcinoma
  • quantum dots
  • radiation therapy
  • lymph node
  • reduced graphene oxide